Abstract
Old technique, new application: A simple and efficient chelator-free strategy for the synthesis of a novel dual-modality PET/MRI agent has been developed. Labeling of radioarsenic (*AsIII and *As V,*=71, 72, 74, 76) at the surface of superparamagnetic iron oxide nanoparticles (SPIONs) resulted in*As-SPIONs that can be used for simultaneous PET/MRI in cancer diagnosis, lymph-node mapping, and potentially for internal radiotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 13319-13323 |
| Number of pages | 5 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 52 |
| Issue number | 50 |
| Early online date | 24 Oct 2013 |
| DOIs | |
| Publication status | Published - 9 Dec 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- arsenic
- cancer
- magnetic resonance imaging
- positron emission tomography
- radiochemistry
ASJC Scopus subject areas
- Catalysis
- General Chemistry
Fingerprint
Dive into the research topics of 'Chelator-free synthesis of a dual-modality PET/MRI agent'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver